BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 15639115)

  • 1. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
    Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
    Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
    Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
    Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].
    de Die-Smulders CE; Faber CG; Smeets HJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2043-6. PubMed ID: 16184945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myotonic dystrophy].
    Nanba E
    Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
    Kumar A; Agarwal S; Agarwal D; Phadke SR
    Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
    Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
    Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic RNA repeats: an expanding role in genetic disease.
    Ranum LP; Day JW
    Trends Genet; 2004 Oct; 20(10):506-12. PubMed ID: 15363905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS; Philips AV; Cooper TA
    Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
    Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
    Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophy: RNA pathogenesis comes into focus.
    Ranum LP; Day JW
    Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.